427 related articles for article (PubMed ID: 15546385)
21. Attenuation of graft arterial disease by manipulation of the LIGHT pathway.
Kosuge H; Suzuki J; Kakuta T; Haraguchi G; Koga N; Futamatsu H; Gotoh R; Inobe M; Isobe M; Uede T
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1409-15. PubMed ID: 15178556
[TBL] [Abstract][Full Text] [Related]
22. LIGHT induces cell proliferation and inflammatory responses of rheumatoid arthritis synovial fibroblasts via lymphotoxin beta receptor.
Ishida S; Yamane S; Ochi T; Nakano S; Mori T; Juji T; Fukui N; Itoh T; Suzuki R
J Rheumatol; 2008 Jun; 35(6):960-8. PubMed ID: 18412315
[TBL] [Abstract][Full Text] [Related]
23. LIGHTing up dendritic cell activation: Immune regulation and viral exploitation.
Pollara G; Katz DR; Chain BM
J Cell Physiol; 2005 Nov; 205(2):161-2. PubMed ID: 16106447
[TBL] [Abstract][Full Text] [Related]
24. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.
Degli-Esposti MA; Davis-Smith T; Din WS; Smolak PJ; Goodwin RG; Smith CA
J Immunol; 1997 Feb; 158(4):1756-62. PubMed ID: 9029113
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of lymphotoxin (LT), lymphotoxin-beta (LT-beta), and TNF-alpha in murine T cell clones activated through the TCR.
Millet I; Ruddle NH
J Immunol; 1994 May; 152(9):4336-46. PubMed ID: 8157957
[TBL] [Abstract][Full Text] [Related]
26. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.
Hochman PS; Majeau GR; Mackay F; Browning JL
J Inflamm; 1995-1996; 46(4):220-34. PubMed ID: 8878796
[TBL] [Abstract][Full Text] [Related]
27. Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiation.
Franki AS; Van Beneden K; Dewint P; Meeus I; Veys E; Deforce D; Elewaut D
Mol Immunol; 2005 Feb; 42(4):413-7. PubMed ID: 15607792
[TBL] [Abstract][Full Text] [Related]
28. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
[TBL] [Abstract][Full Text] [Related]
29. Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes.
Kovanen PE; Young L; Al-Shami A; Rovella V; Pise-Masison CA; Radonovich MF; Powell J; Fu J; Brady JN; Munson PJ; Leonard WJ
Int Immunol; 2005 Aug; 17(8):1009-21. PubMed ID: 15980098
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
31. Molecular cloning and characterization of TNFSF14 (LIGHT) and its receptor TNFRSF14 (HVEM) in guinea pig (Cavia porcellus).
Li C; Chen S; Song J; Liu H; Gu W; Ai H; Zhao B; Zhang S
Gene; 2013 Sep; 526(2):374-84. PubMed ID: 23732292
[TBL] [Abstract][Full Text] [Related]
32. TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes.
Kuprash DV; Alimzhanov MB; Tumanov AV; Anderson AO; Pfeffer K; Nedospasov SA
J Immunol; 1999 Dec; 163(12):6575-80. PubMed ID: 10586051
[TBL] [Abstract][Full Text] [Related]
33. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
[TBL] [Abstract][Full Text] [Related]
34. Differential cellular expression of LIGHT and its receptors in early gestation human placentas.
Gill RM; Coleman NM; Hunt JS
J Reprod Immunol; 2007 Jun; 74(1-2):1-6. PubMed ID: 17010447
[TBL] [Abstract][Full Text] [Related]
35. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.
Hummel M; Kurian SM; Lin S; Borodyanskiy A; Zhang Z; Li Z; Kim SJ; Salomon DR; Abecassis M
Transplantation; 2009 Jan; 87(2):178-88. PubMed ID: 19155971
[TBL] [Abstract][Full Text] [Related]
36. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
[TBL] [Abstract][Full Text] [Related]
37. A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.
Gommerman JL; Giza K; Perper S; Sizing I; Ngam-Ek A; Nickerson-Nutter C; Browning JL
J Clin Invest; 2003 Sep; 112(5):755-67. PubMed ID: 12952924
[TBL] [Abstract][Full Text] [Related]
38. Identification and expression analysis of lymphotoxin-beta like homologues in rainbow trout Oncorhynchus mykiss.
Kono T; Zou J; Bird S; Savan R; Sakai M; Secombes CJ
Mol Immunol; 2006 Mar; 43(9):1390-401. PubMed ID: 16144708
[TBL] [Abstract][Full Text] [Related]
39. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis.
Timmer TC; Baltus B; Vondenhoff M; Huizinga TW; Tak PP; Verweij CL; Mebius RE; van der Pouw Kraan TC
Arthritis Rheum; 2007 Aug; 56(8):2492-502. PubMed ID: 17665400
[TBL] [Abstract][Full Text] [Related]
40. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.
Gommerman JL; Browning JL
Nat Rev Immunol; 2003 Aug; 3(8):642-55. PubMed ID: 12974479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
